+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Clinical and neuropsychological correlates of proton magnetic resonance spectroscopy detected metabolites in brains of first-episode and schizophrenic patients



Clinical and neuropsychological correlates of proton magnetic resonance spectroscopy detected metabolites in brains of first-episode and schizophrenic patients



Psychiatria Polska 37(6): 977-988



This study examined 1H MRS detected metabolite levels (in left frontal, temporal lobes and thalamus) and clinical and cognitive features of patients with first-episode and chronic schizophrenia. We studied 31 first-episode patients (group 1) and 17 chronic patients (group 2) with ICD-10 diagnosis of schizophrenia (and 13 healthy subjects). Patients were also assessed by the means of PANSS, CGI, Calgary scales and WCST, TMT, Stroop tests. We did not observe statistically significant differences in metabolite levels between group 1 and 2. We observed only a trend toward higher Cho level in temporal lobe in group 2 and lower NAA level in group 1. When comparing with the control group we observed a significantly higher Cho level in the frontal lobe (group 1,2) (p < 0.05). We observed a trend toward lower NAA levels in the frontal lobe (group 1,2), and lower NAA level in the temporal lobe (group 1). Patients with chronic schizophrenia performed significantly worse in WCST, TMT and Stroop tests (p < 0.05). These results suggest, that abnormalities in metabolite levels in frontal and temporal lobes are present at the onset of disease and don't progress over time. The cognitive dysfunction is more prominent in chronic patients.

(PDF emailed within 1 workday: $29.90)

Accession: 048537321

Download citation: RISBibTeXText

PMID: 14727370


Related references

Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study. Journal of Psychiatric Research 41(8): 625-634, 2006

Caudate neurochemistry, clinical symptoms, and neuropsychological functioning in first episode schizophrenia: A proton magnetic resonance spectroscopy study. Schizophrenia Research 60(1-Supp-S): 241-242, 2003

Antidepressant effect detected on proton magnetic resonance spectroscopy in drug-naïve female patients with first-episode major depression. Psychiatry and Clinical Neurosciences 63(3): 350-356, 2009

Phospholipid abnormalities in postmortem schizophrenic brains detected by 31P nuclear magnetic resonance spectroscopy: A preliminary study. Psychiatry Research 106(3): 171-180, May 30th, 2001

Differences in brain metabolites between patients with autism and mental retardation as detected by in vivo localized proton magnetic resonance spectroscopy. Journal of Child Neurology 12(2): 91-96, 1997

Human fetal brain metabolites detected with proton magnetic resonance spectroscopy. American Journal of Obstetrics & Gynecology 184(1): S139, January, 2001

The positive effects of high-frequency right dorsolateral prefrontal cortex repetitive transcranial magnetic stimulation on memory, correlated with increases in brain metabolites detected by proton magnetic resonance spectroscopy in recently detoxified alcohol-dependent patients. Neuropsychiatric Disease and Treatment 12(): 2273-2278, 2016

Cerebral abnormalities in patients with cirrhosis detected by proton magnetic resonance spectroscopy and magnetic resonance imaging. Hepatology 25(1): 48-54, 1997

Cerebral changes in patients with liver cirrhosis detected by magnetic resonance imaging and proton magnetic resonance spectroscopy. Gastroenterology 108(4 SUPPL ): A1070, 1995

Alterations of brain metabolites in metachromatic leukodystrophy as detected by localized proton magnetic resonance spectroscopy in vivo. Journal Of Neurology. 241(2): 68-74, 1993

Proton magnetic resonance spectroscopy in chronic schizophrenic patients. Neurosciences 20(SUPPL ): P61-P64, 1994

Proton magnetic resonance spectroscopy-detected myoinositol is increased in children with traumatic brain injury and correlates with neurologic outcome. Annals of Neurology 54(Suppl 7): S153, 2003

Proton magnetic resonance spectroscopy of the brain in schizophrenic and affective patients. Schizophrenia Research 8(1): 43-49, 1992

Proton magnetic resonance spectroscopy of the thalamus and hypothalamus in patients with first-episode depression. Nan Fang Yi Ke Da Xue Xue Bao 29(12): 2442-2445, 2011

Temporal lobe proton magnetic resonance spectroscopy of patients with first-episode psychosis. American Journal of Psychiatry 152(3): 444-446, 1995